Key result
Mesalamine therapy in a 19-year-old male with Crohn's disease was associated with the development of myocarditis, which resolved after discontinuing the drug.
Population
19-year-old male with Crohn's disease
Design
Case_report
Authors
Loading...
Alerts clinicians to consider mesalamine in myocarditis differentials for IBD; hypothesis-generating and requires larger studies for causality.
Case Report (n=1)
Highlights a rare case of mesalamine-induced myocarditis in a young patient with Crohn's disease, emphasizing the importance of recognizing this drug-hypersensitivity reaction and discontinuing the offending agent.
Braga et al. (2013) conducted a case report in Crohn's disease (n=1). Mesalamine was evaluated on Development of myocarditis. Mesalamine therapy in a 19-year-old male with Crohn's disease was associated with the development of myocarditis, which resolved after discontinuing the drug.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: